BioGaia publishes annual report for 2019
Today, BioGaia AB (publ) publishes the Annual Report for the financial year 2019. The report is held available at BioGaia’s website biogaia.com under the section "Investors – Financial reports ". Shareholders and other stakeholders wishing to have the annual report sent to them may request so by email to firstname.lastname@example.org.
This is information that BioGaia AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 06:15pm CET on 26 March 2020.
Latest press releases from BioGaia
16.03.2020 BioGaia signs exclusive agreement in Argentina
11.02.2020 BioGaia’s oral health probiotic L. reuteri Prodentis reduces bleeding of the gums
06.02.2020 BioGaia AB – Year-end report 2019
For additional information please contact
Isabelle Ducellier, Chief Executive Officer, BioGaia, telephone: +46 8 555 293 00 +46 8 555 293 00
BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are sold through local distribution partners in around 100 countries worldwide. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. www.biogaia.com